InvestorsHub Logo
Followers 25
Posts 2452
Boards Moderated 1
Alias Born 03/28/2001

Re: Silvr Surfr post# 758

Wednesday, 03/28/2012 2:21:01 PM

Wednesday, March 28, 2012 2:21:01 PM

Post# of 40503
I am surprised it has been this slow to get there...imo the Syncon patent is big...
Dr. J. Joseph Kim, Inovio's president and CEO, said: "This patent is significant for Inovio. It validates the patentable novelty of our SynCon® technology and vaccines created using this technology. We have filed for additional patents to protect our broad emerging portfolio of SynCon vaccine products against multiple diseases. Furthermore, this issued patent covers an important component of our universal influenza vaccine, which is in clinical development. Inovio's universal flu vaccine is designed to protect against many if not all strains within multiple selected subtypes--most importantly against the perpetually emerging new strains for which there has never been truly preemptive protection."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News